Annual Lung SPORE Workshop (Abstract Submission): Submission #71
Submission information
Submission Number: 71
Submission ID: 110632
Submission UUID: d9ac044b-24ca-4fd2-a7aa-f1b15d8c7e17
Submission URI: /dctd/lungsporemeeting/abstracts
Submission Update: /dctd/lungsporemeeting/abstracts?token=1VwrHDwfDq3eX57YsPzC1m4j2koAYgjV4da0jT5VeMo
Created: Mon, 03/11/2024 - 14:54
Completed: Mon, 03/11/2024 - 14:58
Changed: Thu, 05/09/2024 - 11:48
Remote IP address: 10.208.24.212
Submitted by: Anonymous
Language: English
Is draft: No
Webform: LUNG SPORE Investigator - Abstracts
Submitted to: Annual Lung SPORE Workshop (Abstract Submission)
Michael
Grant
Yale University
Efficacy of afatinib in patients with tumors harboring the uncommon EGFR exon 19 deletion, L747_A750delinsP: a pooled analysis
First Author
Additional Authors
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies
Grant_Yale_Session1.docx76.61 KB
No
Approved to be a Poster Presenter
{Empty}
Poster Submission
{Empty}